We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 17th Feb 2020 13:05

(Sharecast News) - Hikma Pharmatheuticals: Citigroup downgrades to neutral with a target price of 1,980p.

Jupiter Fund Management: Berenberg reiterates hold with a target price of 367p.

Centamin: Berenberg reiterates hold with a target price of 127p.

Hummingbird Resources: Berenberg reiterates buy with a target price of 38p.

MJ Gleeson: Canaccord reiterates hold with a target price of 960p.

Imperial Brands: Deutsche Bank reiterates buy with a target price of 2,400p.

National Grid: Barclays reiterates overweight with a target price of 1,115p.

Segro: Deutsche Bank downgrades to hold with a target price of 810p.

AstraZeneca: UBS reiterates sell with a target price of 5,800p.

Just Eat: Barclays reiterates overweight with a target price 8,500p.

Reckitt Benckiser Group: JP Morgan reiterates overweight with a target price of 8,500p.

Royal Bank of Scotland: JP Morgan reiterates overweight with a target price of 260p.

Ashtead: JP Morgan reiterates overweight with a target price of 3,250p.

Dunelm: RBC reiterates sector performer with a target price of 1,250p.

RELX: UBS reiterates sell with a target price of 1,825p.

Barclays: UBS reiterates buy with a target price of 205p.

Associated British Foods: UBS reiterates buy with a target price of 3,200p.

Meggitt: Citigroup downgrades to neutral with a target price of 730p.

Related Shares

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company rep...

16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract c...

12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugel...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.